Doctor Watson Is In

IBM and the New York Genome Center team up to use Watson to personalize cancer treatment.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Also "devising personalized

Also "devising personalized treatments for glioblastoma patients" is Northwest Biotherapeutics with their DCVax-L treatment, currently in Phase III trial in US, and available immediately in Germany under their Hospital Exemption. Perhaps Watson will pick up on this treatment as it analyzes the medical literature and clinical records. Starting point: Press Releases shown at www.nwbio.com.